Adherence to long-term therapies : (Record no. 33047)

000 -LEADER
fixed length control field 02080cam a22003857a 4500
001 - CONTROL NUMBER
control field 13313664
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20130310193350.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 030515s2003 sz a b i000 0 eng d
010 ## -
-- 2003362254
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9241545992
035 ## -
-- (OCoLC)ocm52253251
040 ## - CATALOGING SOURCE
Original cataloging agency PIT
Transcribing agency UG
Modifying agency VAM
-- DLC
042 ## -
-- lccopycat
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RA644.5
082 00 -
-- 362.16
-- 22
245 00 - TITLE STATEMENT
Title Adherence to long-term therapies :
Remainder of title evidence for action /
Statement of responsibility, etc [edited by Eduardo Sabaté].
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Geneva :
Name of publisher, distributor, etc World Health Organization,
Date of publication, distribution, etc 2003.
300 ## - PHYSICAL DESCRIPTION
Extent xv, 198 p. :
Other physical details col. ill. ;
Dimensions 26 cm.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Ch. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chronic diseases
General subdivision Treatment.
9 (RLIN) 56390
Topical term or geographic name as entry element Patient compliance.
9 (RLIN) 56391
Topical term or geographic name as entry element Medical policy.
9 (RLIN) 56392
Topical term or geographic name as entry element Chronic Disease
General subdivision therapy.
9 (RLIN) 56393
Topical term or geographic name as entry element Health Policy.
9 (RLIN) 56394
Topical term or geographic name as entry element Patient Compliance.
9 (RLIN) 56395
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sabaté, Eduardo.
9 (RLIN) 56396
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element World Health Organization.
9 (RLIN) 56397
906 ## -
-- 7
-- cbc
-- copycat
-- 3
-- ncip
-- 20
-- y-gencatlg
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
955 ## -
-- of21 2003-08-14 to ASCD
-- jc00 2003-09-02;
-- jc09 2003-09-12
-- aa25 2004-08-04
Holdings
Price effective from Permanent Location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Shelving location Barcode Damaged status Lost status Withdrawn status Current Location Full call number
2012-03-29Turkeyen Campus2012-03-29 2011-07-19 Not To Be Taken OutScience & Technology245293   Turkeyen CampusRA644.5